Results 231 to 240 of about 86,631 (266)
Some of the next articles are maybe not open access.

Angiotensin Receptor Blockers and Epoetin Resistance

Seminars in Dialysis, 2003
Edward F, Foote, David, Germick
openaire   +2 more sources

Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore

Physiology, 2021
Juan M Saavedra, Juan M Saavedra
exaly  

The metabolic effects of angiotensin-receptor blockers

Current Hypertension Reports, 2005
Michael L, Tuck, Dalila B, Corry
openaire   +2 more sources

Angiotensin II Receptor Blockers

2001
The angiotensin II (Ang II) receptor antagonists are the most selective blockers of the renin-angiotensin system (RAS) currently available. The efficacy of these drugs is similar to that of the other major antihypertensive drug classes, but they appear to exhibit fewer side effects. Angiotensin receptor blockers (ARBs) selectively block the angiotensin
openaire   +1 more source

Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19

Journal of the American Heart Association, 2021
Tariq Azam   +2 more
exaly  

Angiotensin Receptor Blockers

2007
William J. Elliott, Henry R. Black
openaire   +1 more source

The angiotensin receptor blockers

Journal of Cardiac Failure, 1999
openaire   +1 more source

Home - About - Disclaimer - Privacy